Skip to content

Clinical trials

Phase 3 Breast Neoplasms trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Country / region: Malaysia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20071
20091
20102
20122
20131
20141
20151
20161
20181
20191
20213
20235
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting8
Recruiting6
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Hoffmann-La Roche5
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
Olema Pharmaceuticals, Inc.2
Amgen1
Celcuity Inc1
European Organisation for Research and Treatment of Cancer - EORTC1
Gilead Sciences1
International Breast Cancer Research Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms29
Neoplasm Metastasis6
Breast Diseases2
Neoplasms2
Neoplasms by Site2
Triple Negative Breast Neoplasms2
Anemia1
Breast Neoplasms, Male1
Multiple Endocrine Neoplasia Type 11
Neutropenia1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.